TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/6/22 19:00 | 9/1/22 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson David Lee | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 5 | 10 | 56 | D | ||||||||||||||
8/3/22 18:01 | 8/1/22 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson David Lee | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 7 | 15 | 53 | D | ||||||||||||||
4/5/22 19:00 | 4/1/22 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson David Lee | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 4 | 10 | 48 | D | ||||||||||||||
3/3/22 21:12 | 3/1/22 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson David Lee | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 3 | 6 | 46 | D | ||||||||||||||
2/3/22 17:44 | 2/1/22 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson David Lee | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 7 | 19 | 43 | D | ||||||||||||||
10/5/21 16:05 | 10/1/21 | GBT | Global Blood Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Johnson David Lee | CA | O | Chief Co | M.d | 0 | 0.00 | 0 | 4 | 13 | 39 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |